glp 1 and mast cell GLP-1 GLP-2 Orchestrate Intestine Integrity, Gut Microbiota, and Immune System Crosstalk Can GLP-1 Medications Help MCAS,

In addition, according to observational and experimental data, DPP4 inhibitors [10, 11], sulfonylureas [11, 52], and insulin [53], are unlikely to slow cognitive decline beyond the benefits of glycemic control in diabetes without dementia

The primary treatment in IIH is acetazolamide, but many patients deteriorate and remain unwell despite treatment and the drug also has such severe side effects that our previous trials have shown that 48% of patients stop taking it. Obesity is the major causative risk factor for IIH 2,3 and GLP-1 agonists cause weight loss in both diabetic and non-diabetic patients

[DOI] [PubMed] [Google Scholar] 45.Kim W, et al

It is ineffective against type 1 diabetes because it will not help to increase insulin due to the inactivity of the pancreas in these patients

Semaglutide, sold under the brand names Ozempic, Wegovy and Rybelsus, is an antidiabetic medication used for the treatment of type 2 diabetes and an anti-obesity medication used for long-term weight management, developed by Novo Nordisk in 2012

Carmot Therapeutics is a U.S.-based biotech company focused on developing incretin-based therapies, including CT-388 (a weekly injectable dual GLP-1/GIP agonist), an oral small-molecule GLP-1 agonist (CT-996), and another injectable GLP-1/GIP candidate (CT-868)